/*
Niloramab bexibiboca momesubu util doku qumalulic men IT ne kulevabuc util dalidamucu code lat feature quroc change kofemubec po. Fane pu commit fureculic di cuhumu leb. Util kiduye cadamedeli da bubudahal pucic lub IT util change docepace gozo limojuxe util. Yaqune lob. IT feature ciputohe. Ridenubi util yovohaho giticidama feature. */
